For more than a century, J&J’s logo has been a recreation of co-founder James Wood Johnson’s cursive signature on the company’s first check in 1886, according to the company’s website. The signature will gradually be replaced by a modern version with each letter written in one pen stroke, according to a news release.
The new logo’s launch coincides with a restructuring of its Jansenn pharmaceuticals business, which will be renamed Johnson & Johnson Innovative Medicine. Its medical device and technology segment will continue to be called Johnson & Johnson MedTech.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
